215 related articles for article (PubMed ID: 26437123)
21. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Rocca WA; Knopman DS; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Preboske GM; Pankratz VS; Vemuri P; Petersen RC
Lancet Neurol; 2014 Oct; 13(10):997-1005. PubMed ID: 25201514
[TBL] [Abstract][Full Text] [Related]
22. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
23. Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
Neurology; 2016 Aug; 87(7):691-8. PubMed ID: 27421543
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
25. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Mosconi L; Andrews RD; Matthews DC
J Alzheimers Dis; 2013; 35(3):509-24. PubMed ID: 23478305
[TBL] [Abstract][Full Text] [Related]
26. Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.
Wennberg AM; Gustafson D; Hagen CE; Roberts RO; Knopman D; Jack C; Petersen RC; Mielke MM
J Alzheimers Dis; 2016 May; 53(2):573-81. PubMed ID: 27163809
[TBL] [Abstract][Full Text] [Related]
27. Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.
Ewers M; Brendel M; Rizk-Jackson A; Rominger A; Bartenstein P; Schuff N; Weiner MW;
Neuroimage Clin; 2014; 4():45-52. PubMed ID: 24286024
[TBL] [Abstract][Full Text] [Related]
28. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
29. Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
Bailly M; Destrieux C; Hommet C; Mondon K; Cottier JP; Beaufils E; Vierron E; Vercouillie J; Ibazizene M; Voisin T; Payoux P; Barré L; Camus V; Guilloteau D; Ribeiro MJ
Biomed Res Int; 2015; 2015():583931. PubMed ID: 26346648
[TBL] [Abstract][Full Text] [Related]
30. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Prestia A; Caroli A; Wade SK; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo IH; Nordberg A; Scheltens P; Frisoni GB
Alzheimers Dement; 2015 Oct; 11(10):1191-201. PubMed ID: 25646957
[TBL] [Abstract][Full Text] [Related]
31. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.
Araque Caballero MÁ; Brendel M; Delker A; Ren J; Rominger A; Bartenstein P; Dichgans M; Weiner MW; Ewers M;
Neurobiol Aging; 2015 Nov; 36(11):2913-2924. PubMed ID: 26476234
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
[TBL] [Abstract][Full Text] [Related]
33. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
34. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
35. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Jack CR; Wiste HJ; Weigand SD; Knopman DS; Mielke MM; Vemuri P; Lowe V; Senjem ML; Gunter JL; Reyes D; Machulda MM; Roberts R; Petersen RC
Brain; 2015 Dec; 138(Pt 12):3747-59. PubMed ID: 26428666
[TBL] [Abstract][Full Text] [Related]
36. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
Kljajevic V; Grothe MJ; Ewers M; Teipel S;
Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
[TBL] [Abstract][Full Text] [Related]
37. Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease.
Carter SF; Embleton KV; Anton-Rodriguez JM; Burns A; Ralph MA; Herholz K
AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S18-30. PubMed ID: 24578281
[TBL] [Abstract][Full Text] [Related]
38. Mapping ventricular expansion onto cortical gray matter in older adults.
Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S32-41. PubMed ID: 25311280
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
40. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
